International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients
Sponsor: Children's Hospital of Philadelphia
This observational or N/A phase trial investigates Hemolytic Uremic Syndrome and Thrombotic Microangiopathy and is currently terminated or withdrawn. Children's Hospital of Philadelphia leads this study, which shows 10 recorded versions since 2007 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital of Philadelphia
- Icahn School of Medicine at Mount Sinai
- Mario Negri Institute for Pharmacological Research
- Montreal Children's Hospital of the MUHC
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Northwell Health
- Stollery Children's Hospital
- University of Utah
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • New Hyde Park, United States